Live Chat ×
Skip to main content

A Journey through Diagnostically Challenging Areas in Gynecologic Pathology

Evaluated by: David B. Kaminsky, M.D., FIAC, December 21, 2017
Original release date: December 21, 2017
Access to this course expires on:  September 26, 2020, at 11:59 PM Pacific Time
CME/SAMs 12.25

Course Description 

There are significant new developments in diagnostic gynecologic pathology explicated in the World Health Organization Classification of Tumors of the Female Reproductive Organs, 2014. This systematic educational tool is the reference resource for expert mentors from Harvard, Yale and Stanford to update practicing pathologists with new disease classifications and related diagnostic criteria that will improve performance, guide clinical management of patients and inform further investigations. Challenging cases discussed at multi-head microscopes represent an intimate and interactive learning opportunity. If you seek enrichment, stimulation, knowledge and confidence in diagnosing complex gynecologic pathology cases, this course is for you! 

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Recognize new diagnostic criteria and disease classifications in gynecological pathology
  • Apply morphologic and immunohistochemical criteria for differential diagnoses between gynecological malignancies and their benign mimics
  • Recognize uncommon/unusual gynecological disease entities and their diagnostic criteria
  • Learn the clinical implication when applying new diagnostic knowledge in gynecological pathology

Continuing Medical Education and Maintenance of Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.25  AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 12.25 SAM/Part II credit hours.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Pei Hui, M.D., Ph.D., Natalia Buza, M.D., Teri A. Longacre, M.D., Jennifer N. Stall, M.D., Robert H. Young, M.D., FRCPath

The following IM Coordinator reported no relevant financial relationships: Charles Matthew Quick, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.

Buy the entire A Journey Thorough Diagnostically Challenging Areas in Gynecologic Pathology and get a great discount!

Not A Member? Click Here